Aurora Cannabis Had a Better Quarter than Investors Thought, This Analyst Says

Aurora Cannabis had a better quarter than investors thought, this analyst says

Aurora Cannabis (Aurora Cannabis Stock Quote, Chart, News, Analysts, Financials TSX:ACB) reported stronger fourth-quarter Adjusted EBITDA than any quarter in fiscal 2024, though momentum investors reacted to slowing sequential growth, according to Roth Capital analyst Bill Kirk. In a June 19 note, Kirk reiterated a “Neutral” rating and lowered his 12-month price target to $7 […] Source

Aurora Cannabis Files Full Year 2024, Fiscal 2025 Fourth Quarter Results

EDMONTON, AB – Aurora Cannabis Inc., a leading Canadian global medical cannabis company, reported its financial and operational results for the fourth quarter and fiscal year 2025 periods ending March 31, 2025. “We are pleased to report an exceptional year to our shareholders, highlighted by record annual global medical net revenue, adjusted EBITDA, and positive free cash flow. These achievements underscore the thoughtful execution of our strate…